Logo
x

Search category

Subscribe Now

All Posts by Date

PharmaShots Weekly Snapshots (April 11-15, 2022)

PharmaShots Weekly Snapshots (April 11-15, 2022)

BMS and Nektar End Global Clinical Development Program for Bempegaldesleukin + Opdivo in Renal Cell Carcinoma and Bladder Cancer

BMS and Nektar End Global Clinical Development Program for Bempegaldesleukin + Opdivo in Renal Cell Carcinoma and Bladder Cancer

Boehringer Ingelheim and Autigen Collaborate to Discover and Develop Novel Treatments for Hearing Loss

Boehringer Ingelheim and Autigen Collaborate to Discover and Develop Novel Treatments for Hearing Loss

SonoScape Receives the US FDA’s Approval for its Endoscopy System

SonoScape Receives the US FDA’s Approval for its Endoscopy System

Valneva Received MHRA’s Conditional Marketing Authorization for its Inactivated COVID-19 Vaccine

Valneva Received MHRA’s Conditional Marketing Authorization for its Inactivated COVID-19 Vaccine

Pfizer and BioNTech Seek Approval for Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age

Pfizer and BioNTech Seek Approval for Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age

Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2022 PharmaShots - All Rights Reserved.